{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:53Z","timestamp":1791923933079,"version":"4.3.4"},"reference-count":57,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"DOI":"10.1210\/me.2012-1287","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T05:50:29Z","timestamp":1358315429000},"page":"315-324","source":"Crossref","is-referenced-by-count":130,"title":["Structural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition"],"prefix":"10.1210","volume":"27","author":[{"given":"Natallia","family":"Strushkevich","sequence":"first","affiliation":[{"name":"Structural Genomics Consortium (N.S., L.S., C.H.A., A.M.E., H.-W.P.), University of Toronto, Toronto, Ontario, Canada M5G 1L7;"},{"name":"Department of Pharmacology and Toxicology (N.S., H.-W.P.), University of Toronto, Toronto, Ontario, Canada M5S 1A8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei A.","family":"Gilep","sequence":"additional","affiliation":[{"name":"Institute of Bioorganic Chemistry National Academy of Sciences of Belarus (A.A.G., S.A.U.), Minsk 220141, Belarus;University of Toronto, Toronto, Ontario, Canada M5S 1A8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Shen","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium (N.S., L.S., C.H.A., A.M.E., H.-W.P.), University of Toronto, Toronto, Ontario, Canada M5G 1L7;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl H.","family":"Arrowsmith","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium (N.S., L.S., C.H.A., A.M.E., H.-W.P.), University of Toronto, Toronto, Ontario, Canada M5G 1L7;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aled M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium (N.S., L.S., C.H.A., A.M.E., H.-W.P.), University of Toronto, Toronto, Ontario, Canada M5G 1L7;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Usanov","sequence":"additional","affiliation":[{"name":"Institute of Bioorganic Chemistry National Academy of Sciences of Belarus (A.A.G., S.A.U.), Minsk 220141, Belarus;University of Toronto, Toronto, Ontario, Canada M5S 1A8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Won","family":"Park","sequence":"additional","affiliation":[{"name":"Structural Genomics Consortium (N.S., L.S., C.H.A., A.M.E., H.-W.P.), University of Toronto, Toronto, Ontario, Canada M5G 1L7;"},{"name":"Department of Pharmacology and Toxicology (N.S., H.-W.P.), University of Toronto, Toronto, Ontario, Canada M5S 1A8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041123130181100_B1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/heartjnl-2011-300741","article-title":"Resistant hypertension.","volume":"98","author":"Fagard","year":"2012","journal-title":"Heart"},{"key":"2019041123130181100_B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mnh.0000165889.60254.98","article-title":"Aldosterone and end-organ damage.","volume":"14","author":"Brown","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2019041123130181100_B3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrendo.2009.263","article-title":"Aldosterone and arterial hypertension.","volume":"6","author":"Tomaschitz","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"2019041123130181100_B4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0223-5234(03)00049-7","article-title":"Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis.","volume":"38","author":"Hartmann","year":"2003","journal-title":"Eur J Med Chem"},{"key":"2019041123130181100_B5","first-page":"319","article-title":"Aldosterone synthase inhibitors: pharmacological and clinical aspects.","volume":"10","author":"Jansen","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"2019041123130181100_B6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrcardio.2010.85","article-title":"Novel therapeutic targets for hypertension.","volume":"7","author":"Paulis","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"2019041123130181100_B7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(12)60825-3","article-title":"New drugs, procedures, and devices for hypertension.","volume":"380","author":"Laurent","year":"2012","journal-title":"Lancet"},{"key":"2019041123130181100_B8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/bbrc.1997.6651","article-title":"CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase (P450C18).","volume":"234","author":"Nomoto","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041123130181100_B9","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1073\/pnas.89.11.4996","article-title":"Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency.","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123130181100_B10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1006\/bbrc.1993.1128","article-title":"Congenitally defective aldosterone biosynthesis in humans: inactivation of the P-450C18 gene (CYP11B2) due to nucleotide deletion in CMO I deficient patients.","volume":"190","author":"Mitsuuchi","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041123130181100_B11","first-page":"3525","article-title":"Hereditary defect in biosynthesis of aldosterone: aldosterone synthase deficiency 1964\u20131997.","volume":"82","author":"Peter","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123130181100_B12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/jcem-62-1-225","article-title":"Biochemical diagnosis and management of corticosterone methyl oxidase type II deficiency.","volume":"62","author":"Lee","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123130181100_B13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production.","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123130181100_B14","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1016\/S0021-9258(19)30030-4","article-title":"Characterization of two genes encoding human steroid 11\u03b2-hydroxylase (P-450(11)\u03b2).","volume":"264","author":"Mornet","year":"1989","journal-title":"J Biol Chem"},{"key":"2019041123130181100_B15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF03344112","article-title":"Aldosterone and the conquest of land.","volume":"29","author":"Colombo","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"2019041123130181100_B16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0303-7207(99)00051-9","article-title":"Adrenal zonation: clues from 11\u03b2-hydroxylase and aldosterone synthase.","volume":"151","author":"Rainey","year":"1999","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123130181100_B17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1097-2765(00)80408-6","article-title":"Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.","volume":"5","author":"Williams","year":"2000","journal-title":"Mol Cell"},{"key":"2019041123130181100_B18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0076-6879(02)57667-9","article-title":"Purification and crystallization of N-terminally truncated forms of microsomal cytochrome P450 2C5.","volume":"357","author":"Wester","year":"2002","journal-title":"Methods Enzymol"},{"key":"2019041123130181100_B19","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1073\/pnas.1019441108","article-title":"Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system.","volume":"108","author":"Strushkevich","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123130181100_B20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbrc.2006.12.047","article-title":"Adrenodoxin supports reactions catalyzed by microsomal steroidogenic cytochrome P450s.","volume":"353","author":"Pechurskaya","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041123130181100_B21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of x-ray diffraction data collected in oscillation mode.","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol"},{"key":"2019041123130181100_B22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography.","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2019041123130181100_B23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0108767390010224","article-title":"Improved methods for building protein models in electron density maps and the location of errors in these models.","volume":"47","author":"Jones","year":"1991","journal-title":"Acta Crystallogr A"},{"key":"2019041123130181100_B24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1107\/S0907444998003254","article-title":"Crystallography, NMR system: a new software suite for macromolecular structure determination.","volume":"54","author":"Br\u00fcnger","year":"1998","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2019041123130181100_B25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","article-title":"Structural basis of human CYP51 inhibition by antifungal azoles.","volume":"397","author":"Strushkevich","year":"2010","journal-title":"J Mol Biol"},{"key":"2019041123130181100_B26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0006-291X(05)81058-7","article-title":"Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism.","volume":"173","author":"Kawainoto","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041123130181100_B27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/mend-5-10-1513","article-title":"The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex.","volume":"5","author":"Curnow","year":"1991","journal-title":"Mol Endocrinol"},{"key":"2019041123130181100_B28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1073\/pnas.89.4.1458","article-title":"Role of steroid 11\u03b2-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans.","volume":"89","author":"Kawamoto","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123130181100_B29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2012.03.002","article-title":"Human aldosterone synthase: recombinant expression in E. coli and purification enables a detailed biochemical analysis of the protein on the molecular level.","volume":"132","author":"Hobler","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041123130181100_B30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.toxlet.2012.07.020","article-title":"Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21, as well as CYP3A4 in xenobiotic androgen elimination. Insights from metandienone metabolism.","volume":"213","author":"Parr","year":"2012","journal-title":"Toxicol Lett"},{"key":"2019041123130181100_B31","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1210\/en.2007-1015","article-title":"Cyp11b1 is induced in the murine gonad by luteinizing hormone\/human chorionic gonadotropin and involved in the production of 11-ketotestosterone, a major fish androgen: conservation and evolution of the androgen metabolic pathway.","volume":"149","author":"Yazawa","year":"2008","journal-title":"Endocrinology"},{"key":"2019041123130181100_B32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jmb.2009.11.057","article-title":"Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism.","volume":"396","author":"Annalora","year":"2010","journal-title":"J Mol Biol"},{"key":"2019041123130181100_B33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural basis for androgen specificity and oestrogen synthesis in human aromatase.","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"key":"2019041123130181100_B34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/oxfordjournals.annonc.a010635","article-title":"First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20\/88.","volume":"7","author":"Th\u00fcrlimann","year":"1996","journal-title":"Ann Oncol"},{"key":"2019041123130181100_B35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/01.hjh.0000226183.98439.b3","article-title":"Can the dextroenantiomer of the aromatase inhibitor fadrozole be useful for clinical investigation of aldosterone-synthase inhibition?","volume":"24","author":"M\u00e9nard","year":"2006","journal-title":"J Hypertens"},{"key":"2019041123130181100_B36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ab.2009.07.025","article-title":"Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors.","volume":"394","author":"LaSala","year":"2009","journal-title":"Anal Biochem"},{"key":"2019041123130181100_B37","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1021\/jm901356d","article-title":"Synthesis, biological evaluation, and molecular modeling of 1-benzyl-1H-imidazoles as selective inhibitors of aldosterone synthase (CYP11B2).","volume":"53","author":"Roumen","year":"2010","journal-title":"J Med Chem"},{"key":"2019041123130181100_B38","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI106974","article-title":"Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading.","volume":"51","author":"Williams","year":"1972","journal-title":"J Clin Invest"},{"key":"2019041123130181100_B39","first-page":"2203s","article-title":"Glucocorticoid resistance in humans and nonhuman primates.","volume":"49","author":"Brandon","year":"1989","journal-title":"Cancer Res"},{"key":"2019041123130181100_B40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1677\/joe.0.1390301","article-title":"11\u03b2-Hydroxylase gene expression in the rat adrenal cortex.","volume":"139","author":"Ho","year":"1993","journal-title":"J Endocrinol"},{"key":"2019041123130181100_B41","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1111\/j.1742-4658.2005.04977.x","article-title":"Molecular identification of adrenal inner zone antigen as a heme-binding protein.","volume":"272","author":"Min","year":"2005","journal-title":"FEBS J"},{"key":"2019041123130181100_B42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mce.2011.06.026","article-title":"Non-adrenal synthesis of aldosterone: a reality check.","volume":"350","author":"MacKenzie","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123130181100_B43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbapap.2010.06.021","article-title":"At the crossroads of steroid hormone biosynthesis: the role, substrate specificity and evolutionary development of CYP17.","volume":"1814","author":"Gilep","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2019041123130181100_B44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0039-128X(96)00172-9","article-title":"The regulation of 17,20 lyase activity.","volume":"62","author":"Miller","year":"1997","journal-title":"Steroids"},{"key":"2019041123130181100_B45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"2019041123130181100_B46","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","article-title":"Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123130181100_B47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nsb0197-32","article-title":"The amino acid substitutions Ser288Gly and Val320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme.","volume":"4","author":"Curnow","year":"1997","journal-title":"Nat Struct Biol"},{"key":"2019041123130181100_B48","first-page":"3996","article-title":"Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol.","volume":"83","author":"Mulatero","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123130181100_B49","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1074\/jbc.271.14.8028","article-title":"Engineering a mineralocorticoid- to a glucocorticoid-synthesizing cytochrome P450.","volume":"271","author":"B\u00f6ttner","year":"1996","journal-title":"J Biol Chem"},{"key":"2019041123130181100_B50","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1074\/jbc.M111.323501","article-title":"Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants.","volume":"287","author":"Zhao","year":"2012","journal-title":"J Biol Chem"},{"key":"2019041123130181100_B51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0076-6879(02)57661-8","article-title":"Sequence alignments, variabilities, and vagaries.","volume":"357","author":"Graham","year":"2002","journal-title":"Methods Enzymol"},{"key":"2019041123130181100_B52","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4155\/fmc.10.229","article-title":"Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by x-ray crystallography and NMR.","volume":"2","author":"Gay","year":"2010","journal-title":"Future Med Chem"},{"key":"2019041123130181100_B53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1432-1327.1998.2520458.x","article-title":"Conferring aldosterone synthesis to human CYP11B1 by replacing key amino acid residues with CYP11B2-specific ones.","volume":"252","author":"B\u00f6ttner","year":"1998","journal-title":"Eur J Biochem"},{"key":"2019041123130181100_B54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0960-0760(94)00152-C","article-title":"Enzyme-activated inhibitors of steroidal hydroxylases.","volume":"52","author":"Johnston","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041123130181100_B55","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1021\/jm3004637","article-title":"Selective dual inhibitors of CYP19 and CYP11B2: targeting cardiovascular diseases hiding in the shadow of breast cancer.","volume":"55","author":"Hu","year":"2012","journal-title":"J Med Chem"},{"key":"2019041123130181100_B56","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1021\/jm100317b","article-title":"Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17\/CYP11B1 inhibitors for the treatment of prostate cancer.","volume":"53","author":"Hu","year":"2010","journal-title":"J Med Chem"},{"key":"2019041123130181100_B57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK\u2014a program to check the stereochemical quality of protein structures.","volume":"26","author":"Laskowski","year":"1993","journal-title":"J Appl Crystallogr"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/27\/2\/315\/10722201\/mend0315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T01:46:26Z","timestamp":1644111986000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/27\/2\/315\/2615115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2012-1287","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}